Magnesium taurate
Magnesium taurate, also known as magnesium ditaurate,[1] is the magnesium salt of taurine, and a mineral supplement.
Names | |
---|---|
IUPAC name
Magnesium 2-aminoethanesulfonate | |
Other names
Magnesium ditaurate | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider | |
PubChem CID |
|
UNII | |
| |
| |
Properties | |
C4H12MgN2O6S2 | |
Molar mass | 272.57 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
It contains 8.9% elemental magnesium by mass. Accordingly, 100 mg of magnesium is contained in 1121 mg of magnesium taurate.
Research
Magnesium taurate has been studied in rats for delaying the onset and progression of cataract.[2]
Safety
Due to the expected dissociation of magnesium taurate in the body before absorption, safety data on magnesium and taurine can be used to evaluate the safety of magnesium taurate.[1]
Taurine has an observed safe level of supplemental intake in normal healthy adults at up to 3 g/day.[3] Using the same level as an approximation for taurate yields a limit of 3.3 g/day for magnesium taurate, or alternatively 300 mg/day for elemental magnesium as taurate.
See also
- Magnesium (pharmaceutical preparation)
- Magnesium deficiency (medicine)
- Magnesium in biology
References
- "Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food on iron (II) taurate, magnesium taurate and magnesium acetyl taurate as sources for iron or magnesium to be added as a nutritional substance in food supplements following a request from the European Commission" (PDF). 2009.
• Synonyms for magnesium taurate are: magnesium taurinate, magnesium 2-aminoethane sulfonic acid and magnesium ditaurate.
• Due to the expected dissociation of magnesium taurate in the body before absorption, data on magnesium and taurate (or taurine) can be used to evaluate the safety of magnesium taurate. - Agarwal R, Iezhitsa I, Awaludin NA, Ahmad Fisol NF, Bakar NS, Agarwal P, Abdul Rahman TH, Spasov A, Ozerov A, Mohamed Ahmed Salama MS, Mohd Ismail N (2013). "Effects of magnesium taurate on the onset and progression of galactose-induced experimental cataract: in vivo and in vitro evaluation". Experimental Eye Research. 110: 35–43. doi:10.1016/j.exer.2013.02.011. PMID 23428743.
Both in vivo and in vitro studies demonstrated that treatment with magnesium taurate delays the onset and progression of cataract in galactose fed rats by restoring the lens Ca(2+)/Mg(2+) ratio and lens redox status.
- Shao A, Hathcock JN (2008). "Risk assessment for the amino acids taurine, L-glutamine and L-arginine". Regulatory Toxicology and Pharmacology. 50 (3): 376–99. doi:10.1016/j.yrtph.2008.01.004. PMID 18325648.
the newer method described as the Observed Safe Level (OSL) or Highest Observed Intake (HOI) was utilized. The OSL risk assessments indicate that based on the available published human clinical trial data, the evidence for the absence of adverse effects is strong for Tau at supplemental intakes up to 3 g/d, Gln at intakes up to 14 g/d and Arg at intakes up to 20 g/d, and these levels are identified as the respective OSLs for normal healthy adults.